Advisor Group, Inc. - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 21 filers reported holding AKARI THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$2,0001,029
+4016.0%
0.00%
Q1 2019$0250.0%0.00%
Q4 2018$0250.0%0.00%
Q3 2018$0250.0%0.00%
Q2 2018$0250.0%0.00%
Q1 2018$0250.0%0.00%
Q4 2017$0250.0%0.00%
Q3 2017$0
-100.0%
25
-99.6%
0.00%
-100.0%
Q2 2017$29,0006,381
+25424.0%
0.00%
Q1 2017$0250.0%0.00%
Q4 2016$0250.0%0.00%
Q3 2016$0250.0%0.00%
Q2 2016$0250.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q4 2017
NameSharesValueWeighting ↓
Hikari Power Ltd 1,000,000$2,560,0000.26%
Endurant Capital Management LP 163,609$419,0000.19%
Vivo Capital, LLC 345,850$885,0000.09%
NEA Management Company, LLC 452,167$1,158,0000.05%
Truvestments Capital LLC 4,122$11,0000.01%
MILLENNIUM MANAGEMENT LLC 27,296$70,0000.00%
MORGAN STANLEY 229$1,0000.00%
BANK OF MONTREAL /CAN/ 15,000$38,0000.00%
Parallax Volatility Advisers, L.P. 7,500$19,0000.00%
FNY Investment Advisers, LLC 200$00.00%
View complete list of AKARI THERAPEUTICS PLC shareholders